Global Operations
News
Career
HOME
About
Company Overview
Mission & Vision
Heritage
Key Facts
Chairman's Message
Board Of Directors
Human Resource
Awards & Accolades
Corporate View
Products
Pharma
General
By Brand Name
By Generic Name
By Therapeutic Class
Ophthalmic
By Brand Name
By Generic Name
By Therapeutic Class
Natural
Herbal
By Brand Name
Unani
Investors
Price Sensitive Information
Financial Report
Shareholder Center
Corporate Governance
Code of Conduct for the Board
Dividend Policy Statement
Dividend History
Unclaimed Dividend Information
Newspaper Notice
Weekly Share Price
Event & Presentation
Notice
Investors' Contact
Commitments
Our Approach
Patient Safety
Workplace
Communities
Environmental Sustainability
Sales and Marketing Practice
Stake Holders
Ethics
Business Operation
Approach to GMP
Manufacturing
Facilities
Quality & Compliance
Marketing, Sales & Distribution
Contact
Head Office
Factory
Marketing & Sales
Home / Investors / Notice
Price Sensitive Information
Financial Report
Shareholder Center
Corporate Governance
Weekly Share Price
Event & Presentation
Notice
Investors' Contact
Notice
29th March 2016
Meeting of The Board of Directors
2nd October 2016
Price Sensitive Informaion (239th Board Meeting) for the period of January-June 2016
13th November 2016
First Quarter Financial Statement-2016-17 (Un-Audited)
13th February 2017
Investors Ralated Information for Investment
1st March 2017
Price Sensitive Information
27th January 2018
Price Sensitive Information (Half Year 2017-18)
8th March 2018
Price Sensitive Information (Purchase a Land)
6th November 2018
First Quarter Financial Statement- 2018-19
10th November 2020
36th AGM Notice 2020
31st July 2021
Unclaimed Dividend Notice
27th October 2021
37th AGM Notice 2021
25th October 2022
38th AGM Notice 2022
